8-K

UNITEDSTATESSECURITIES AND EXCHANGE COMMISSION

Washington,D.C. 20549

FORM8-K

CURRENTREPORT

Pursuantto Section 13 or 15(d) of the Securities Exchange Act of 1934

Dateof Report (Date of earliest event reported): May 14, 2020

JRSISHEALTH CARE CORPORATION

(Exact name of registrant as specified in its charter)

No.38 South Street, Hulan District, Harbin City

HeilongjiangProvince, P.R. China 150025

(Address of Principal Executive Office) (Zip Code)

86-451-56888933

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item8.01 Other Events.

On March 4, 2020, pursuant to Section 36 of the Securities Exchange Act of 1934, the Securities and Exchange Commission issued Release No. 34-88318 (the “Order”) granting exemptions to registrants subject to the reporting requirements of the Exchange Act Section 13(a) or 15(d) due to circumstances related to the coronavirus disease 2019 (COVID-19).

JRSIS Health Care Corporation is furnishing this Current Report on Form 8-K to indicate its reliance on the Order in connection with the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2019.

The Company’s headquarters and operations are located in the City of Harbin, China. Due to the ongoing outbreak of the COVID-19, the Chinese government initiated travel restrictions and mandatory quarantines to control the spread of COVID-19 within China. These actions taken by the Chinese government have prevented the Company’s accounting department from completing the financial data and related materials necessary for the first quarter financial statements to be completed in a timely manner. As a result, the Company will be unable to file the Form 10-Q by May 15, 2020.

The Company expects to file its Quarterly Report on Form 10-Q within 45 days after May 15, 2020.

The Company is also publishing the following Risk Factor:

Thespread of COVID-19 through the population of the City of Harbin and the mandatory quarantines imposed by the government to stopthe spread have significantly interfered with the business of Jiarun Hospital, which will have a significant adverse effect onour income and profitability.

TheCompany’s only business activity is ownership and operation of Jiarun Hospital (including its two satellites), the largest hospitalin the City of Harbin. Many residents of Harbin have contracted COVID-19 during the current pandemic. As a result, the nationaland local government have imposed serious restrictions on business operations within the City, including mandatory quarantines.The quarantines have prevented Jiarun Hospital from carrying on its normal operations. As a result, the Company’s revenue andincome for the first six months of 2020 will be substantially lower than were reported for the first six months of 2019.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

2